Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nephrolithiasis
ADR ID BADD_A03021
ADR Hierarchy
20      Renal and urinary disorders
20.04      Urolithiases
20.04.01      Renal lithiasis
20.04.01.002      Nephrolithiasis
Description Formation of stones in the KIDNEY. [MeSH]
MedDRA Code 10029148
MeSH ID D053040; D007669
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Calculus kidney | Calculus of kidney | Calculus of kidney and ureter | Calculus renal | Calculus renal NOS | Crystallization kidney | Kidney calculus | Kidney crystallisation | Kidney stone | Kidney stones | Nephrolithiasis | Renal calculi | Renal calculus | Renal calculus NOS | Renal stone | Uric acid nephrolithiasis | Unilateral renal calculus | Kidney crystallization | Crystallisation kidney | Renal pelvic calcification | Nephrolithiasis recurrent | Gouty diathesis | Ureteropelvic junction stone | Renal microlithiasis | Bilateral nephrolithiasis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00586Darunavir0.002713%
BADD_D00594Deferasirox0.028128%
BADD_D00604Delavirdine mesylate--
BADD_D00620Desoximetasone--
BADD_D00621Desvenlafaxine0.000178%
BADD_D00652Dichlorphenamide0.001003%
BADD_D00674Diltiazem--
BADD_D00676Dimenhydrinate--
BADD_D00680Dimethyl fumarate0.018523%
BADD_D00701Dofetilide0.000127%
BADD_D00718Doxazosin0.000113%
BADD_D00719Doxazosin mesylate--
BADD_D00734Duloxetine--
BADD_D00749Efavirenz0.005505%
BADD_D00759Eltrombopag0.000915%
BADD_D00765Empagliflozin0.001784%
BADD_D00771Enfuvirtide--
BADD_D00774Entecavir0.003269%
BADD_D00775Enzalutamide--
BADD_D00788Epoprostenol0.000345%
BADD_D00790Eprosartan--
BADD_D00791Eprosartan mesylate--
BADD_D00794Ergocalciferol0.001710%
BADD_D00809Escitalopram--
BADD_D00837Eszopiclone--
BADD_D00850Etodolac--
BADD_D00865Ezogabine--
BADD_D00870Febuxostat0.002291%
BADD_D00898Finasteride0.000881%
BADD_D00932Fluoxetine--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 10 Pages